REQUEST A DEMO
Total
USD $0.00
Search more companies

Ginwa Enterprise (Group) Inc. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ginwa Enterprise (Group) Inc. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The Company was established as a joint stock limited companyin 1996. on the basis of Xian Jindu Biological Pharmacy Ltd., which was set up in 1993 . With the approval of ChinaSecurities Regulatory Commission , the Company's A shareswere listed on Shanghai Stock Exchange on June 12, 1997. It is a high-tech listed company specialized in the biopharmaceutical and medical logistics, whose existing products include hundreds of products, bio-pharmaceuticals, biochemical medicines, Chinese and Western medicines, health products. Its main products are transfer factor oral / capsules, artificial tiger bone meal /Jintiange capsule, Jinhua Liantangsu, Beizong, Ketai, Yixiqing, Youben, etc. The sales network covers 30 provinces and autonomous regions. In 2005, it ranked 41th in the top 100 pharmaceutical companies in China for two consecutive years. The artificial tiger bone meal (a state class A new drug, currently the world's only natural substitute for tiger bone) was listed as "National High-Tech Industries Demonstration Project".

Headquarters
202 Tech. Rd. Xi'an Shanxi
Xi'an; Shaanxi; Postal Code: 710075

Contact Details: Purchase the Ginwa Enterprise (Group) Inc. report to view the information.

Website: http://www.ginwa.com.cn

Basic Information
Total Employees:
Purchase the Ginwa Enterprise (Group) Inc. report to view the information.
Outstanding Shares:
Purchase the Ginwa Enterprise (Group) Inc. report to view the information.
Registered Capital:
Purchase the Ginwa Enterprise (Group) Inc. report to view the information.
Financial Auditors:
Purchase the Ginwa Enterprise (Group) Inc. report to view the information.
Incorporation Date:
February 14, 1996
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
19.63%
Purchase this report to view the information.
5.04%
Purchase this report to view the information.
5.01%
Purchase this report to view the information.
2.94%
Purchase this report to view the information.
2.83%
Subsidiaries
Changchun Jinhua Pharmaceutical Co., Ltd.
100%
Golden Flower International Hotel Co., Ltd.
100%
Jinhua Huikang Pharmaceutical (Hainan) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Ginwa Enterprise (Group) Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
55.05%
Total operating revenue
53.29%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
11.42%
Total assets
6.17%
Total equity
0.02%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.33%
Return on Equity (ROE)
0.02%
Quick Ratio
-0.86%
Cash Ratio
-0.88%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?